New York is currently home to 4446 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Consent for Use of Stored Patient Specimens for Future Testing
Recruiting
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Gender:
ALL
Ages:
All
Trial Updated:
09/20/2024
Locations: SUNY / Erie County Med Ctr at Buffalo, Buffalo, New York
Conditions: HIV Infections
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
Recruiting
This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.
Gender:
ALL
Ages:
30 years and above
Trial Updated:
09/19/2024
Locations: Scheer Medical Wellness, New York, New York
Conditions: Osteoarthritis, Knee
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Recruiting
The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2024
Locations: NYP/Weill Cornell Medicine, New York, New York
Conditions: Colorectal Cancer, Endometrial Cancer, Hereditary Cancer Syndromes
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Recruiting
The purpose of this randomized trial is to conduct a fully powered effectiveness trial of video-delivered PROTECT (Tele-PROTECT) compared to a video-delivered depression education (DepEd) control condition to be delivered to 140 English- and Spanish-speaking NYC elder abuse victims. Investigators hypothesize three main aims: 1. Effectiveness Aim: Tele-PROTECT participants will have significantly greater and clinically meaningful reductions in depression when compared to the DepEd control; 2. Ab... Read More
Gender:
ALL
Ages:
60 years and above
Trial Updated:
09/19/2024
Locations: Weill Cornell Medicine, New York, New York
Conditions: Depression, Elder Abuse
Study of JANX007 in Subjects with Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Recruiting
This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate cancer (mCRPC).
Gender:
MALE
Ages:
Between 18 years and 100 years
Trial Updated:
09/19/2024
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Castration Resistant Prostatic Cancer
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
Recruiting
The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
09/19/2024
Locations: NYU Langone Health, New York, New York
Conditions: Lower Limb Injury
Registry for Patients with Erdheim-Chester Disease and Other Histiocytoses
Recruiting
The investigators want to understand more about what kinds of health problems are caused by histiocytosis, what happens as a result of different treatments, and how ECD affects people's lives, their feelings and their attitudes. The investigators also want to learn how these things change over time for people with these conditions. To try to figure this out, doctors would like to collect information about people who have histiocytosis and how they are treated for this disease. Some participants... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/19/2024
Locations: Memorial Sloan Kettering Cancer Center, New YorK, New York
Conditions: Erdheim-Chester Disease
To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Recruiting
The goal of this clinical trial is to evaluate the efficacy of using SP-002 in participants with locally advanced Basal cell carcinoma. The main question it aims to answer is what the objective response rate for a basal cell carcinoma tumor is following 1 or 3 cycles of SP-002 treatment given as an add-on to hedgehog pathway inhibitor therapy. Researchers will compare the objective response rate for treated Basal cell carcinoma tumors between 3 treatment Arms. * Arm 1 participants will receive... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: Research Site, Rochester, New York
Conditions: Basal Cell Carcinoma
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Recruiting
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary biological and clinical activity of BMS-986458, a bifunctional cereblon-dependent ligand-directed degrader (LDD) of BCL6 (BCL6 LDD), as a single agent and in combination with anti-lymphoma agents in participants with relapsed/refractory non-Hodgkin Lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success, New York
Conditions: Relapsed/Refractory Non-Hodgkin Lymphoma
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Recruiting
The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM). The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM. They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.
Gender:
ALL
Ages:
Between 30 years and 85 years
Trial Updated:
09/18/2024
Locations: Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack, New York
Conditions: Malignant Pleural Mesothelioma
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Recruiting
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: Lenox Hill Hospital/Staten Island University Hospital, New York, New York
Conditions: Nasal Obstruction, Septal Defect, Allergic Rhinitis, Nasal Polyps, Nasal Valve Collapse
PREPARE: Patient Centered Perioperative Experience
Recruiting
The purpose of this study is to determine whether an educational video about patients' perioperative experience (period that spans from the time of admission to the hospital to the time of recovery after surgery) will affect the timing of hospital discharge. The researchers will use information collected during this study to create a questionnaire and an educational video related to the patient perioperative experience. The educational video will address patient concerns about the perioperative... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
09/18/2024
Locations: Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York
Conditions: Minimally Invasive Surgery (MIS) Hysterectomy